ethyl (1S,2R,3S,4R,5R)-2,3-dihydroxy-4-(4-(phenethylamino)-2-(phenylethynyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)bicyclo[3.1.0]hexane-1-carboxylate

ID: ALA5169644

Chembl Id: CHEMBL5169644

PubChem CID: 168271011

Max Phase: Preclinical

Molecular Formula: C31H30N4O4

Molecular Weight: 522.61

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOC(=O)[C@]12C[C@@H]1[C@@H](n1ccc3c(NCCc4ccccc4)nc(C#Cc4ccccc4)nc31)[C@H](O)[C@@H]2O

Standard InChI:  InChI=1S/C31H30N4O4/c1-2-39-30(38)31-19-23(31)25(26(36)27(31)37)35-18-16-22-28(32-17-15-21-11-7-4-8-12-21)33-24(34-29(22)35)14-13-20-9-5-3-6-10-20/h3-12,16,18,23,25-27,36-37H,2,15,17,19H2,1H3,(H,32,33,34)/t23-,25-,26+,27+,31-/m1/s1

Standard InChI Key:  ZPZDGGXNORFAFM-YOLPVHPBSA-N

Alternative Forms

  1. Parent:

    ALA5169644

    ---

Associated Targets(Human)

ABCG2 Tchem ATP-binding cassette sub-family G member 2 (4927 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA3 Tchem Adenosine A3 receptor (15931 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2A Tclin Adenosine A2a receptor (16305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRK1 Tclin Kappa opioid receptor (16155 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRD1 Tclin Delta opioid receptor (15096 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRM1 Tclin Mu opioid receptor (19785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Adora3 Adenosine A3 receptor (257 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 522.61Molecular Weight (Monoisotopic): 522.2267AlogP: 3.33#Rotatable Bonds: 7
Polar Surface Area: 109.50Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.12CX Basic pKa: 5.08CX LogP: 4.78CX LogD: 4.78
Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.25Np Likeness Score: -0.09

References

1. Abel B, Murakami M, Tosh DK, Yu J, Lusvarghi S, Campbell RG, Gao ZG, Jacobson KA, Ambudkar SV..  (2022)  Interaction of A3 adenosine receptor ligands with the human multidrug transporter ABCG2.,  231  [PMID:35152062] [10.1016/j.ejmech.2022.114103]
2. Jacobson KA, Salmaso V, Suresh RR, Tosh DK..  (2021)  Expanding the repertoire of methanocarba nucleosides from purinergic signaling to diverse targets.,  12  (11.0): [PMID:34825182] [10.1039/D1MD00167A]

Source